Lpl Financial LLC Acadia Pharmaceuticals Inc Transaction History

Lpl Financial LLC

$238 Billion
Q4 2024

A detailed history of Lpl Financial LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Lpl Financial LLC holds 26,370 shares of ACAD stock, worth $528,454. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,370

Previous 73,413 64.08%

Holding current value

$528,454

Previous $1.13 Million 57.22%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$14.29 - $18.76 $672,244 - $882,526	-47,043 Reduced 64.08%	26,370 $483,000
Q3 2024 Nov 08, 2024	BUY	$15.14 - $19.14 $15,230 - $19,254	1,006 Added 1.39%	73,413 $1.13 Million
Q2 2024 Aug 07, 2024	BUY	$14.62 - $18.42 $182,969 - $230,526	12,515 Added 20.9%	72,407 $1.18 Million
Q1 2024 May 10, 2024	SELL	$17.79 - $30.86 $56,536 - $98,073	-3,178 Reduced 5.04%	59,892 $1.11 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $100,325 - $153,385	4,828 Added 8.29%	63,070 $1.97 Million
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $121,914 - $195,799	5,850 Added 11.17%	58,242 $1.21 Million
Q2 2023 Jul 31, 2023	BUY	$17.8 - $25.65 $101,602 - $146,410	5,708 Added 12.23%	52,392 $1.25 Million
Q1 2023 May 10, 2023	BUY	$16.32 - $20.92 $148,952 - $190,936	9,127 Added 24.3%	46,684 $878,000
Q4 2022 Feb 07, 2023	SELL	$14.2 - $18.63 $2,243 - $2,943	-158 Reduced 0.42%	37,557 $597,000
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $13,263 - $17,173	-940 Reduced 2.43%	37,715 $617,000
Q2 2022 Aug 12, 2022	SELL	$13.01 - $27.22 $8,950 - $18,727	-688 Reduced 1.75%	38,655 $545,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $28,310 - $37,180	1,352 Added 3.56%	39,343 $953,000
Q4 2021 Feb 14, 2022	SELL	$16.79 - $27.09 $229,636 - $370,509	-13,677 Reduced 26.47%	37,991 $887,000
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $72,745 - $114,189	4,610 Added 9.8%	51,668 $858,000
Q2 2021 Aug 13, 2021	BUY	$19.4 - $27.42 $137,604 - $194,490	7,093 Added 17.75%	47,058 $1.15 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $35,928 - $78,965	-1,436 Reduced 3.47%	39,965 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$41.04 - $56.79 $171,013 - $236,643	4,167 Added 11.19%	41,401 $2.21 Million
Q3 2020 Nov 09, 2020	BUY	$36.42 - $57.0 $15,223 - $23,826	418 Added 1.14%	37,234 $1.54 Million
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $27,992 - $37,596	713 Added 1.97%	36,816 $1.78 Million
Q1 2020 May 14, 2020	SELL	$31.65 - $46.87 $647,685 - $959,147	-20,464 Reduced 36.18%	36,103 $1.53 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $120,615 - $171,213	3,331 Added 6.26%	56,567 $2.42 Million
Q3 2019 Nov 13, 2019	SELL	$22.22 - $44.01 $1.56 Million - $3.1 Million	-70,344 Reduced 56.92%	53,236 $1.92 Million
Q2 2019 Aug 09, 2019	BUY	$23.32 - $28.12 $106,922 - $128,930	4,585 Added 3.85%	123,580 $3.3 Million
Q1 2019 May 08, 2019	SELL	$16.17 - $27.38 $34,118 - $57,771	-2,110 Reduced 1.74%	118,995 $3.2 Million
Q4 2018 Feb 07, 2019	SELL	$14.32 - $22.92 $138,374 - $221,475	-9,663 Reduced 7.39%	121,105 $1.96 Million
Q3 2018 Nov 14, 2018	SELL	$13.03 - $21.81 $130,117 - $217,794	-9,986 Reduced 7.09%	130,768 $2.72 Million
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $137,890 - $204,411	-9,150 Reduced 6.1%	140,754 $2.15 Million
Q1 2018 May 15, 2018	SELL	$22.47 - $32.33 $197,016 - $283,469	-8,768 Reduced 5.53%	149,904 $3.37 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $1.76 Million - $2.56 Million	65,517 Added 70.33%	158,672 $4.78 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $35,388 - $46,044	1,200 Added 1.3%	93,155 $3.51 Million
Q2 2017 Aug 14, 2017	BUY	N/A	91,955	91,955 $2.57 Million

Others Institutions Holding ACAD

# of Institutions

306

Shares Held

157M

Call Options Held

828K

Put Options Held

317K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.24B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Acadia Pharmaceuticals Inc Transaction History